↓ Skip to main content

Dove Medical Press

Article Metrics

Treatment and management of myelofibrosis in the era of JAK inhibitors [Corrigendum]

Overview of attention for article published in Biologics: Targets & Therapy, October 2013
Altmetric Badge

Mentioned by

twitter
1 tweeter

Readers on

mendeley
1 Mendeley
Title
Treatment and management of myelofibrosis in the era of JAK inhibitors [Corrigendum]
Published in
Biologics: Targets & Therapy, October 2013
DOI 10.2147/btt.s54093
Pubmed ID
Authors

Claire Harrison, Deepti Deepti Radia, Clodagh Keohane

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 1 Mendeley reader of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 1 100%

Demographic breakdown

Readers by professional status Count As %
Unknown 1 100%
Readers by discipline Count As %
Unknown 1 100%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 October 2013.
All research outputs
#3,486,818
of 4,505,550 outputs
Outputs from Biologics: Targets & Therapy
#96
of 114 outputs
Outputs of similar age
#79,905
of 102,515 outputs
Outputs of similar age from Biologics: Targets & Therapy
#7
of 7 outputs
Altmetric has tracked 4,505,550 research outputs across all sources so far. This one is in the 2nd percentile – i.e., 2% of other outputs scored the same or lower than it.
So far Altmetric has tracked 114 research outputs from this source. They receive a mean Attention Score of 2.3. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 102,515 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one.